Tabitha Lobo

Cardiology Fellow @WashUCardiology via @CWRUIM | Rooted in Goa, sprouting in St. Louis

[Tabitha Lobo @TabithaLobo]

Glad to have attended #ASPC2023- it was well-organized, fun & educational, with topics that were current, applicable & relevant to the world of preventive cardiology.
Honored to have received first place in the early career research competition! Thanks to @ASPCardio & my mentors.

[Tabitha Lobo @TabithaLobo]

Honored to have been able to present our research at #ASPC2023 on a topic that’s close to my ❤️(pun unintended!)
@deo_salil @Sadeer_AlKindi @khurramn1 @SarjuGanatraMD @IMotairek @ASPCardio

[Claire Cambron @ClaireCambron]

Exposure to air pollution is an important non-traditional CVD risk factor‼️

Dr. Tabitha Lobo presents her research at #ASPC2023 on CVD burden due to air pollution in South Asia:

⚠️Death & disability-adjusted life years due to ambient particulate matter have doubled in 30 yrs

[Willington Amutuhaire. @amutuhair]

Tabitha & I at 2023 American Society of preventive Cardiology’s Congress in Arlington Tx. Great learning from outstanding prevention cardiologists. Colchicine is a new kid on the block for decreasing CV events.
#ASPC2023
@CaseUHmed
@TabithaLobo
@clongen82
@m2smooth

[Tabitha Lobo @TabithaLobo]

New in #JACCHF: Is there clinical value in trending NT-proBNP levels after initiation of ARNI in HFrEF?
Read about it: https://t.co/jVeFWcS7K7
#JACC #HeartFailure #CardioTwitter #CardioEd #JACCHF @JACCJournals

[Sadeer Al-Kindi, MD @Sadeer_AlKindi]

In a study of >1 m patients with T2D, @deo_salil et al shows that the social environment is an important determinant of incidenr and recurrent HF risk in T2D. Time to consider the neighborhood environment for risk stratification https://t.co/Ly9k88N4pD (open access)

[Tabitha Lobo @TabithaLobo]

New in #JACCHF: How can we reduce the risk of incident heart failure? https://t.co/Vph5R8d5UD
#HeartFailure #CVD #CardioTwitter #Hypertension #CardioEd #JACCHF @JACCJournals

[Tabitha Lobo @TabithaLobo]

Clinical psychologist and outcomes researcher @KimGSmolderen spoke about the biopsychosocial model of health. One of her areas of interest is a vital focus of research— mental health and cardiovascular disease.
#FMD @FMDartery #CVD #MentalHealthAwareness #PAD #VascularMedicine

[Tabitha Lobo @TabithaLobo]

An informative and enjoyable weekend at the FMDSA 2023 annual conference learning all about FMD from the experts! Always glad to hang out with this awesome vascular team.. #FMD #FMDSA @FMDartery @pdmace2 @heatherlgornik @KimGSmolderen

[Tabitha Lobo @TabithaLobo]

“What’s important to you?” Wonderful job by @EstherSHKimMD and the rest of team, using the iSCAD registry to answer questions of the patients #SCAD #FMD #FMDSA @FMDartery @iSCADregistry @iSCADregistry @AtriumHealth @SCADalliance

[Tabitha Lobo @TabithaLobo]

Breaking down SCAD for you.. @EstherSHKimMD #FMD #FMDSA @FMDartery #SCAD @iSCADregistry @SCADalliance @AtriumHealth

[Tabitha Lobo @TabithaLobo]

“What we have learned from the FMD registry” Current initiatives and future potential for research using the FMD registry by @heatherlgornik
#FMD #FMDSA @DrJeffreyWOlin1 @FMDartery @pdmace2

[Tabitha Lobo @TabithaLobo]

When to suspect Renal FMD?” by Dr. Natalia Fendrikova Mahlay. Keep your eyes out and ears (for the swoosh!) too.. to recognize FMD! #FMD #FMDSA @FMDartery @ccfvascmed @ClevelandClinic

[Tabitha Lobo @TabithaLobo]

Excellent talk by @shazamhussain on “Bulges and Tears- managing brain aneurysms and dissections in FMD” about techniques and technologies in the world of vascular neurology #FMD #FMDSA @FMDartery #vascularneurology #endovascular @pdmace2 @CLENeurons @ClevelandClinic

[Tabitha Lobo @TabithaLobo]

New in #JACCHF: How should cardiac transplant centers be evaluated?
https://t.co/55V427NwGP
#HeartFailure #CardiacTransplant #HF

[Tabitha Lobo @TabithaLobo]

@amutuhair @CaseUHmed @LukandeRobert @rkalyes1 @m2smooth Congrats Willington!! Excellent job

[Landsberg Manual @LandsbergManual]

Thank you to @OrlandoRPN and your followers,
Ver. 2
Initial Evaluation and Management of Septic Shock
#sepsis #SHOCK #emergencymedicine #MedEd #MedTwitter #hospitalist #internalmedicine #criticalcare #pulmonary #infectiousdiseases #pccm #icunurse PRTIYL #anesthesiology

[Sadeer Al-Kindi, MD @Sadeer_AlKindi]

Really glad to be part of this effort to apply AI approaches on CAC for CV risk prediction

"CWRU, UH Researchers Get $6.2M to Study AI for Cardiovascular Disease Prediction"
https://t.co/koclADvLCX

[Heather L Gornik @heatherlgornik]

.@KaremHarthMD reviews core elements of duplex protocols for assessment of pelvic venous insufficiency @HarringtonHVI @UHVascular

[Eiran Gorodeski, MD, MPH @EiranGorodeski]

Advanced Heart Failure & Transplant Cardiology: What happened in the 2023 Match? @TheNRMP More programs than ever (n=73; n=127 positions offered) want to train advanced HF specialists, but the interest is flat (n=71 positions filled). A small number (n=28) of large fairly homogeneous programs will train heart transplant specialists. These future graduates will look for jobs in similar large homogenous hospital systems, many of which are already saturated and have no positions to offer. Some will be frustrated when they don't get this type of job. My hope instead is that HF graduates look beyond and recognize that there are n=6500 hospitals in the United States, and many are desperate to hire visionary leaders and HF program builders. Here is my plea: Please be brave and take those real-world jobs. Millions of patients with HF will never meet a specialist HF cardiologist. https://t.co/AAiUUz64hg

[Tabitha Lobo @TabithaLobo]

New in #JACCHF: Using cardiac biomarkers to reclassify 'at risk' adults from Stage A to Stage B HF can help target earlier preventive strategies in individuals at higher risk for HF and death.
Featuring @EiranGorodeski's podcast: https://t.co/uAcf91AlUK
📎https://t.co/FWKQSAb8Ha